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NF-Y is a trimeric transcription factor containing H2A/H2B-like subunits, which specifically binds to the CCAAT
box, a common eukaryotic promoter element. To gain insights into NF-Y-dependent transcriptional regulation, we
assessed its relationships with positive histone marks by chromatin immunoprecipitation-on-chip and correlative-
profiling studies. Unbiased identification of binding sites shows that the majority of genes are bound by NF-Y in the
promoter and/or within the coding region. Parallel analysis of H3K9-14ac and H3K4me3 sites indicates that NF-Y
loci can be divided in two distinct clusters: (i) a large cohort contains H3K9-14ac and H3K4me3 marks and
correlates with expression and (ii) a sizeable group is devoid of these marks and is found on transcriptionally silent
genes. Within this class, we find that NF-Y binding is associated with negative histone marks, such as H4K20me3
and H3K27me3. NF-Y removal by a dominant negative NF-YA leads to a decrease in the transcription of expressed
genes associated with H3K4me3 and H3K9-14ac, while increasing the levels of many inactive genes. These data
indicate that NF-Y is embedded in positive as well as in negative methyl histone marks, serving a dual function in
transcriptional regulation, as an activator or as a repressor.
Promoters and enhancers that activate RNA polymerase II
(Pol II)-transcribed mRNA genes are formed by a combinato-
rial puzzle of short sequences recognized by sequence-specific
regulators. Among such elements, the CCAAT box is known to
be one of the most frequent. This has been illustrated by
several unbiased bioinformatic studies of large sets of verte-
brate promoters (16, 19, 21, 29, 35, 48, 57). Testing has shown
that the CCAAT box significantly contributes to promoter
activity (34).
Different entities contain the word CCAAT in their acro-
nyms, but several types of evidence indicate that NF-Y, also
termed CBF and HAP2/3/5 for Saccharomyces cerevisiae, is the
CCAAT regulator. (i) Highly specific antibodies were used in
supershift electrophoretic mobility shift assays and chromatin
immunoprecipitations (ChIPs) with a plethora of different pro-
moters (33; D. Dolfini and R. Mantovani, unpublished data).
(ii) Specific dominant negative NF-YA vectors were employed
in cotransfection and adenovirus infection experiments. (iii)
Nucleotides flanking the CCAAT box emerged in the bioin-
formatic studies cited above, with perfect matches to NF-Y
preferences, as assayed by in vitro binding studies (15). It is
therefore reasonable to conclude that NF-Y is by far the major
protein that regulates this element.
NF-Y is a ubiquitous heteromeric transcription factor (TF)
composed of three subunits, NF-YA, NF-YB, and NF-YC, all
necessary for DNA binding (34). NF-YB and NF-YC contain
conserved histone fold motifs composed of three alpha helices
separated by short loop/strand regions (42). NF-YB/NF-YC
association is essential for NF-YA binding and sequence-spe-
cific DNA interactions. Interestingly, CCAAT boxes are
present at a specific location within promoters, typically be-
tween 60 and 100 bp from the transcriptional start site
(TSS). Within this context, NF-Y is not a powerful activator
but rather a promoter organizer that cooperates with the ac-
tivity of neighboring TFs. The emergence of genome-wide
technologies now allows a look at TF binding in a more sys-
tematic and unbiased way. Previous studies, performed with
CpG island arrays and with an oligonucleotide array represen-
tative of a small set of human promoters, left us with an
inconclusive picture as to the widespread NF-Y distribution in
vivo (12, 51).
Moreover, the simple annotation of TF binding sites is not
per se sufficient to obtain satisfactory functional information,
since most TFs are known to act in a peculiar chromatin en-
vironment, defined by patterns of histone posttranslational
modifications. Some of them are associated with accessible,
transcriptionally active chromatin, others with repressive het-
erochromatin, either constitutive or facultative (reviewed in
references 4 and 43). In particular, H3K4 trimethylation
(H3K4me3) and H3K9-14 acetylations (H3K9-14ac) are asso-
ciated with an active chromatin environment in regions and
promoters that are transcribed or poised for rapid induction by
external stimuli (26, 44, 46). Their presence in vivo has been
detailed at the single-gene level, and location analysis con-
firmed their widespread distribution in the proximity of pro-
moters (2, 6, 23, 25, 26, 30, 31, 39, 40, 41). Interestingly, while
the presence of these marks precedes gene activation, an in-
crease in their levels is generally noticed in systems of inducible
transcription. In NF-Y-dependent endoplasmic reticulum
stress promoters, for example, a substantial increase in H3
acetylation and H3K4me3 was seen after induction, while
NF-Y binding was detailed before (3, 14). On the other hand,
posttranslational modifications such as H3K9, H3K27, and
H4K20 methylations are known to be associated with inactive
or actively repressed areas of the genome (4, 18, 38, 47). In
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general, understanding the relationship between histone mod-
ifications and TF binding is quite relevant; it is not completely
clear, at the moment, whether the binding of certain factors is
required for specific modifications to be brought in through
recruitment of histone-modifying enzymatic machines or
whether the binding of TFs is allowed only by a preexisting
nucleosomal environment with an appropriate pattern of his-
tone modifications. To shed light on the relationship between
NF-Y and active histone marks, we used high-density tiling
arrays of chromosomes 20, 21, and 22 in ChIP-on-chip exper-
iments.
MATERIALS AND METHODS
Cells, infections, and PCR analysis. HeLa cells were grown in Dulbecco’s
modified Eagle’s medium supplemented with 10% fetal calf serum, 1% antibi-
otics (penicillin and streptomycin), and L-glutamine in 5% CO2. HCT116 p53/
cells were grown in McCoy’s medium. Infection of HCT116p53/ and HeLa
cells with Ad-YAm29, Ad-NF-YA, and Ad-GFP adenoviruses was carried out as
described previously (27). Semiquantitative ChIP PCR and reverse transcription-
PCR (RT-PCR) analyses were performed according to standard procedures, in
the linear range of amplification, essentially as previously described (12).
ChIP, amplicon generation, and ChIP on chip. ChIPs were performed essen-
tially as described previously (51). Briefly, 5  106 cell equivalents of chromatin,
0.5 kb, were immunoprecipitated with 15 g of anti-YB, anti-H3K4me3 (Abcam),
and anti-H3K9-14ac (Upstate) antibodies. Immunoprecipitation-enriched DNAs
were used to generate amplicons for hybridization experiments. Parallel ChIPs were
run with a Flag control antibody (Sigma), and bona fide NF-Y targets were used to
check enrichments before and after the amplification steps. The generation of
amplicons from the individual ChIPs was performed by following the protocol of
ligation-mediated PCR previously described (9, 54). Design of the oligonucleotides,
preparation of the slides, hybridization, and scanning of the fluorescence intensities
were performed by Nimblegen. Validations of the results by semiquantitative PCR
were performed on independent, nonamplified ChIPs using primers listed in File S1
in the supplemental material. Negative-histone-mark ChIPs were also performed as
described previously (51) using anti-H3K9me3 (Abcam), -H3K27me3 (Abcam), and
-H4K20me3 (Upstate) antibodies.
ChIP-on-chip data analysis. The Cy5 and Cy3 raw data obtained from each
experiment were normalized by subtracting the median and then adding back the
average median of the two channels. The independent median normalization was
chosen since channel distributions were not parametric and therefore the mean
was not suitable. This approach does not perturb the detection of biologically
relevant peaks, while allowing efficient removal of noise due to unbalance be-
tween the two channels (not shown). After single-channel normalization, the
Cy5/Cy3 ratio was calculated for each probe and then converted in the corre-
sponding Z score. This kind of transformation is useful when seeking to compare
the relative standings of items from distributions with different means and/or
standard deviations and fitted our requirement of performing comparison be-
tween different arrays. Box-and-whisker plots clearly showed that Z-score con-
version allowed for a direct comparison of independent data sets derived from
biological replicates (not shown). Peak search was then performed essentially as
previously reported (9), with the so called “peak first” approach. A given per-
centile threshold was chosen for all experiments, and all probes with enrichment
values greater than the percentile were selected. An NF-Y “peak” was defined as
a stretch of at least three adjacent probes (spaced by no more than 150 bp on the
genomic sequence) exceeding the percentile threshold. In H3K9-14ac and
H3K4me3 experiments, five adjacent probes were considered to define a peak. A
hypergeometric P-value-based distribution was then associated with the peaks
obtained. Finally, peaks obtained from the different experiments were merged,
and a given peak was predicted as biologically relevant if present in at least two
out of four experiments for NF-Y or two out of three experiments for active
histone marks, with corresponding probability values computed with a binomial
distribution.
Profiling experiments. The GEO GSE6022 data set, containing a total of three
untreated HeLa cell samples, each being a biological replicate, was used for
HeLa profiling experiments. The GEO GSE6207 data set, containing seven
untreated samples, was used for HepG2 profiling experiments. The data set from
Sato et al. (45), containing three untreated samples, each being a biological
replicate (Affimetrix HG-U133-A platform), was used for human embryonic
stem (ES) cell profiling experiments. The GEO GSE8884 (Affimetrix HG-U133
plus 2.0 platform) was also used for the latter analysis, yielding essentially the
same results despite the larger coverage of the platform (not shown).
Expression signals for microarray data were calculated according to the rma
algorithm and used for quality control. Absent (A) and present (P) calls were
also calculated according to the open-source version of the MAS5 algorithm and
used both for quality control and comparisons. A gene was called P if it was
present at least in two out of three of the samples. The same rules were applied
for A calls. A gene was called UN if it did not fall in the previous categories. The
A, P, and UN groups have no overlaps. The details of the analysis are available
upon request.
RESULTS
A widespread distribution of NF-Y binding in CCAAT pro-
moters. To assay the prevalence of NF-Y binding on CCAAT
promoters, we performed ChIP analysis with an anti-NF-YB
antibody on chromatins derived from seven different cell lines.
We checked 25 randomly picked CCAAT-containing promot-
ers of chromosome 21 genes. Figure 1 indicates that most of
the promoters were indeed bound by NF-Y in the majority of
cells. However, the degree of enrichment over a control Flag
antibody varied substantially and was arbitrarily divided into
three levels: high (30-fold), medium (5- to 30-fold), and low
(2- to 5-fold). The expression patterns of these genes were then
analyzed according to available Unigene transcriptome data
and divided into two broad categories: genes that were ubiq-
uitously expressed and those that had a tissue or cell type
preference. With few exceptions, TMEM50B, RUNX1, and
DSCR1, the high- and medium-enrichment genes, were all in
the ubiquitous category and bound by NF-Y in all cell lines.
Four genes, CLDN17, TMPRSS3, AIRE, and ERG, all tissue
specific, were negative in all cell lines. Finally, weakly enriched
sites were mostly found on tissue-specific genes. We conclude
that (i) NF-Y is bound to the majority of CCAAT-containing
promoters and (ii) the highest enrichment correlates with a
ubiquitous expression profile.
NF-Y ChIP on chip on tiling arrays. To define in an unbi-
ased way the “landscape” of NF-Y binding in vivo, we per-
formed NF-YB ChIP-on-chip analysis in HeLa cells with a
tiling array containing all nonrepetitive sequences of the entire
chromosome 21 and large parts of chromosomes 20 and 22.
Fifty-mer oligonucleotides are tiled every 50 bp, giving a high
degree of resolution and an overall representation of 2.2% of
the human genome. To obtain maximal definition of the loca-
tions, ChIPs were performed using chromatin shorter than 500
bp, with a mean size of 250 to 300 bp. The enrichments present
in the starting ChIPs were assayed against a Flag control an-
tibody and were routinely 100-fold when checked on bona
fide NF-Y target genes (see File S2 in the supplemental ma-
terial). Four NF-YB probes derived from independent ChIPs
were Cy5 labeled and hybridized together with the correspond-
ing Cy3 input DNA, used as an internal control. After normal-
ization of single channels, ratios between NF-YB and input
probes were calculated and converted to Z scores (see Mate-
rials and Methods for details). An NF-Y peak was defined as a
set of at least three consecutive probes whose Z scores devi-
ated significantly from the average of normalized data. Typi-
cally, selected ratios were above 1.8 to 2.3 depending on the
replicate. Only peaks present in at least two out of four repli-
cates were collected for further analysis. Overall, the number
of NF-Y binding sites ranged from 757 to 2,120, depending on
the stringency applied (P values between 1.65 and 1.44). The
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ChIPs performed for Fig. 1 served as a guide for data analysis:
none of the NF-Y-negative promoters was scored, while a
majority of the positives were retrieved (Table 1), and, with the
fourth stringency considered, 14/16 positives were recovered
(see File S3 in the supplemental material).
Binding sites were then classified and divided into three
main categories: (i) “promoters” (PR), describing NF-Y loca-
tions residing from 2 kb to 0.5 kb relative to the TSS of a
GenBank RefSeq sequence and representing 9 to 11% of the
total depending on the stringency; (ii) “genes” (GE), indicating
NF-Y locations residing within RefSeq-annotated genes; and
(iii) “elsewhere” (EL), referring to locations external to pro-
moters and intergenic regions. The last two categories each
accounted for 42 to 48% of the sites.
Independent ChIP validations were performed on 35 loci
derived from the less-stringent criteria: all NF-Y promoter loci
tested scored positive in standard ChIPs and so did 11/15 sites
among the “genes” cohort (see File S3 in the supplemental
material). Thus, based on the prevalidation and validation
ChIPs, the highest stringency reported in Table 1 highly un-
derscored the extent of NF-Y binding and the 1.434 strin-
gency reflected more closely the actual targets, with 10 to 15%
false positives/negatives. Moreover, since the co-occurrence of
nearby positive probes is expected to be enriched in location
analysis, we monitored our peak finding procedure by random-
izing each experimental track; as expected, this procedure dra-
matically reduced the number of loci identified (see File 4 in
the supplemental material), confirming the robustness of our
FIG. 1. NF-Y binding to CCAAT promoters in vivo. Twenty-five randomly picked CCAAT promoters from chromosome 21 were analyzed by
ChIP with anti-NF-YB antibody on chromatin derived from seven different cell lines. Enrichment over that for an irrelevant Flag control antibody
was assessed by semiquantitative PCR and classified as high (30-fold), medium (5- to 30-fold), or low (2- to 5-fold). Colored boxes indicate
positivity and gray boxes indicate no enrichment in ChIPs. The bottom line refers to percentages of NF-Y-positive sites for each cell line. The
expression patterns of the respective genes were analyzed according to available transcriptome data (UniGene build no. 186) and reported on the
right. UB (ubiquitous) refers to genes expressed in at least 10 out of 45 body sites of UniGene’s EST Profile Viewer, while TS (tissue specific) refers
to genes showing expression in less than 10 body sites.
VOL. 28, 2008 HISTONE-LIKE NF-Y, A BIFUNCTIONAL TRANSCRIPTION FACTOR 2049
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approach. Therefore, we pursued further analysis mainly fo-
cusing on this stringency.
We next analyzed NF-Y sites in terms of transcriptional
units (TUs), defined as University of California, Santa Cruz,
RefSeq-annotated genes (hg17 assembly) with their respective
promoters; overall, there are 907 TUs (with no redundant
promoter) within the regions considered here. As expected, by
comparing the number of NF-Y promoter locations with that
of the corresponding TUs (191 versus 196), we could recover,
on average, one location per positive promoter. A different
picture emerged for NF-Y GE category sites, since the number
of NF-Y TUs was significantly lower than the overall number
of locations: 430 versus 1,020. Considering that some of these
locations referred to overlapping or divergent units, this im-
plies that on average two or three NF-Y binding sites were
found per positive TU.
FIG. 2. Categories and locations of NF-Y binding sites. (A) NF-Y promoter sites were plotted according to their positions with respect to the
TSS. The frequencies of GE sites versus their distance from the TSS are also represented. EL sites were classified as present within 5 kb to the
5 or 3 end of an annotated gene, as present within a GenBank-annotated human mRNA not corresponding to a RefSeq (hmRNAs), or far from
annotated genes (other). (B) Venn diagrams showing the overlap between NF-Y TUs containing a site in the promoter and those containing a site
within the body of the gene.
TABLE 1. NF-Y location analysis: binding sites and TUs
Stringency (P)
Binding sites TUs (n  907a)
Rate of recovery of
prevalidated
promoters from HeLa
cells (from Fig. 1)
Total no.
% (no.) for: % (no.) for:
Allb NF-Y NF-Y
PR GE EL PR GE
1 (1.06E05) 757 11.1 (84) 45.4 (344) 43.5 (329) 9.8 (89) 26.1 (237) 298 9/16 0/9
2 (2.88E05) 1,176 9.7 (114) 46.9 (551) 43.5 (511) 13.6 (123) 34.8 (316) 386 11/16 0/9
3 (6.79E05) 1,533 8.9 (137) 47.4 (727) 43.6 (699) 16.0 (145) 40.4 (366) 446 11/16 0/9
4 (1.43E04) 2,120 9.0 (191) 48.1 (1,020) 42.9 (909) 21.6 (196) 47.4 (430) 519 14/16 0/9
a From RefSeq.
b Nonredundant TUs.
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We also analyzed in greater detail the distribution of NF-Y
sites (Fig. 2A). Within PR, most sites reside in the core area,
as expected. Within GE, the site distribution shows a relatively
steep decline as a function of the distance from the TSS, in
agreement with a relevant role for NF-Y at the 5 ends of
genes. Interestingly, we found that more than 50% of NF-Y
promoters possess an additional NF-Y site within the body of
the gene (Fig. 2B). Within the EL category, one-third of the
locations overlap (20%) or are nearby (9%  4%) GenBank-
annotated mRNAs with no RefSeq definition, which are most
likely sites of Pol II activity (Fig. 2A).
Presence of CCAAT boxes in NF-Y locations. It was of in-
terest to assess whether NF-Y locations contain CCAAT
boxes. For this analysis, we considered a short interval of 500
bp centered on the peak, which is most likely a stringent but
reliable window considering the length of the original chroma-
tin (see File S2 in the supplemental material). The pentanucle-
otide was found in 61.6% of total locations, with a higher
percentage in PR and lower in GE (Table 2). We also calcu-
lated the overall number of CCAAT boxes per location. Based
on purely statistical considerations, the expected frequency is
around 1 CCAAT box/location; a specific enrichment was
clearly evident in PR, since 2 to 2.5 CCAAT boxes per pro-
moter were present (Fig. 3). For the GE and EL locations, a
lower enrichment of 1.5 to 1.7 CCAAT boxes per location was
scored. Hence, we conclude that CCAAT boxes are present
and overrepresented in most NF-Y locations.
Correlation between NF-Y, H3K9-14ac, and H3K4me3. Cer-
tain histone modifications are hallmarks of open chromatin
clusters, at least in differentiated cells (4, 44). To characterize
NF-Y sites in terms of the chromatin environment, we ana-
lyzed H3K9-14 acetylations and H3K4 trimethylation on the
same tiling platform (Table 3; see File S5 in the supplemental
material). A clear proof of the robustness of this approach was
gained by comparison of our data with those of Bernstein et al.
(6), obtained with HepG2 cells, since an overlap 80% was
scored for most features analyzed (for details see File S5A to
G in the supplemental material). Briefly, our analysis was con-
sistent with previous results, showing a strong but not absolute
correlation (i) between H3K4me3 and H3K9-14ac and (ii)
between these marks and gene expression. Moreover, the po-
sitions of H3K9-14ac and H3K4me3 sites with respect to TSS
were clearly skewed toward the 5 ends of the genes (see File
S6 in the supplemental material) and this was particularly
evident for H3K4me3. In the case of H3K4me3-positive pro-
moters, comparison with the data set of Guenther et al., ob-
tained from human ES cells (23), was also reassuring: on av-
erage, an overlap of 80% between the two cell lines was scored
(see File S5I to K in the supplemental material). Validation of
these marks in independent ChIPs confirmed that the vast
majority of sites are indeed true positives (see File S3 in the
supplemental material). Hence, we felt comfortable in analyz-
ing the NF-Y loci together with H3K4me3 and H3K9-14ac
sites derived from our ChIP-on-chip analysis.
By combining the three different ChIP-on-chip data sets, we
observed that the majority of NF-Y promoters were also
H3K9-14ac or H3K4me3 (68% and 61%, respectively [Fig.
4A, left]); a good proportion, 57%, contained both marks.
Correlative P values were highly significant. Within NF-Y
genes, the percentage of H3K9-14ac GE sites was higher, at
85%, while the percentage of H3K4me3 GE sites was lower,
at 42%, and, consequently, the percentage of NF-Y genes
double positive for histone marks was also around 40% (Fig.
4A, right). However, the correlation between NF-Y and active
histone marks within this category was stronger, with a P value
of E27 for NF-Y H3K9-14ac H3K4me3 genes, indicat-
ing that essentially all of NF-Y/H3K4me3 sites were also
acetylated. Somewhat surprisingly, we noticed that a sizeable
set of NF-Y TUs were neither acetylated nor trimethylated,
both within promoters (27%) and within the bodies of the
genes (18%). This cluster was unexpected, at least in these
proportions, and was further analyzed below.
When we reversed the analysis, asking how many H3K9-14ac
and/or H3K4me3TUs were bound by NF-Y, we found that 28%
of H3K9-14ac and 30% of H3K4me3 promoters were also
NF-Y (Fig. 4B, left); this is quite significant, considering the
promoters that are not active in HeLa cells (see below) and
considering that the overall percentage of NF-Y promoters was
21% (Table 1). Within the GE category the percentage of H3K9-
14ac TUs positive for NF-Y was 64% and the percentages of
double positives were as high as 79% (Fig. 4B, right). A repre-
TABLE 2. NF-Y sites containing at least one CCAAT box
Category
% (no.) of sites containing a CCAAT box (	150 bp) at stringency:
1 (P  1.06E05) 2 (P  2.88E05) 3 (P  6.79E05) 4 (P  1.43E04)
Total 63.3% (479) 62.8% (739) 61.8% (947) 61.6% (1306)
PR 70.2% (59) 71.1% (81) 66.4% (91) 63.4% (121)
GE 59.6% (205) 59.3% (327) 58.5% (425) 58.6% (598)
EL 66.3% (218) 64.8% (331) 64.4% (431) 64.6% (587)
FIG. 3. CCAAT boxes in NF-Y locations. Average numbers of
CCAAT boxes present in the different NF-Y location categories were
plotted for the four stringencies initially considered. This number was
calculated based on the actual mean dimensions of the identified NF-Y
binding sites, ranging from 460 to 560 bp depending on the stringency,
divided by the theoretical occurrence of the pentanucleotide CCAAT
(once per 512 bp).
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sentative cluster of five genes is shown in Fig. 4C, with two diver-
gent promoters positive for NF-Y binding and for active histone
marks, and one, DONSON, devoid of the former. Altogether,
these data indicate a significant correlation between NF-Y bind-
ing and these histone modifications, either within promoters or
within the bodies of the genes, and highlight a smaller population
of NF-Y-positive locations that are neither H3K9-14 acetylated
nor H3K4 trimethylated.
Correlation between NF-Y, H3K9-14ac, H3K4me3, and gene
expression. Next, we interrogated the list of NF-Y TUs with
respect to both histone marks and expression using available
HeLa profiling data sets obtained on the Affymetrix U133 2.0 Plus
platform. Overall, 59% of the 907 TUs analyzed here were in the
P set and 39% in the A set. As expected, the majority, 75%, of
NF-Y promoters followed P calls (Fig. 5A). NF-Y genes
showed modest skewing toward expression, with P calls at 67%
(Fig. 5B). We then integrated the active histone mark data into
this analysis. Within promoters, the NF-Y H3K9-14ac and
NF-Y/H3K4me3 clusters showed clear skewing toward P calls,
and even more did the triple-positive NF-Y/H3K9-14ac/
H3K4me3 clusters; only a residual 10% of TUs were scored as
A in the latter class (Fig. 5A). On the other hand, the NF-Y/
H3K9-14ac/H3K4me3 promoters were strongly enriched in A
calls (Fig. 5A), indicating (i) that NF-Y is bound at these pro-
moters in the absence of active histone marks and (ii) that this
cohort of genes is not expressed. A somewhat similar situation
emerged for NF-Y genes: enrichment of NF-Y/H3K9-14ac/
H3K4me3 clusters toward expression was less evident, but once
again the majority of NF-Y/H3K9-14ac/H3K4me3 genes
were found in A calls (Fig. 5B). To gain insights into this dual
behavior, NF-Y-positive TUs were subjected to functional enrich-
ment analysis after dividing them into those containing at least
one active histone mark and those devoid of both modifications.
Pathways expected to be positively affected by NF-Y (cell cycle,
cell signaling) were present in the NF-Y/H3K9-14ac/
H3K4me3 cohort of genes, but no single function was over-
whelmingly enriched; this is consistent with the notion that NF-Y
is a broad transcriptional regulator, with specific roles in certain
cellular functions (see File S7A in the supplemental material). A
different picture emerged with NF-Y TUs devoid of active
marks, since functions expected to be repressed in HeLa cells,
sensory perception and immune response, were enriched (see
File S7B in the supplemental material). A graphic representation
of an NF-Y/H3K9-14ac/H3K4me3 locus, SUHW1, is shown
in Fig. 5C, and the complete list of NF-Y/H3K9-14ac/
H3K4me3 TUs is reported in File S8 in the supplemental ma-
terial. Altogether, these data indicate that NF-Y binding is asso-
ciated with two different chromatin states and opposite functional
outcomes: in the presence of the two active histone marks, NF-Y
is bound to expressed loci; binding within areas devoid of these
modifications is coupled to inactive genes.
NF-Y associates with chromatin with negative histone
marks. We further investigated the cluster of nonexpressed NF-
Y/H3K9-14ac/H3K4me3 TUs. To assay the possibility that
negative histone marks were present in these areas, we performed
ChIP experiments with antibodies directed against H3K9me3,
H3K27me3, and H4K20me3, which have been associated, in var-
ious terms, with inactive or partially inactive chromatin environ-
ments (8, 19). As shown in Fig. 6, with one exception, these loci
were confirmed to be NF-Y positive, most of them with a low or
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medium enrichment level compared to genes targeted by NF-Y
and transcribed, such as the SON gene (Fig. 6, top).
Interestingly, all 12 tested sites scored positive for H4K20me3,
as did 7 out of 12 for H3K27me3; among these SUHW1, encoding
the human homologue of Drosophila Suppressor of Hairy-wing
insulator binding protein, and the vitamin D receptor-activated
CYP24A1; only three sites, APOBEC3, FTCD, and C21orf81,
were H3K9me3. Reassuringly, with just one exception, ChIPs
confirmed negativity for the active histone mark H3K4me3 (not
shown). These results are consistent with the idea that NF-Y can
be associated in vivo with areas of the genome containing nega-
tive histone marks.
NF-Y is an activator as well as a repressor. The binding of
a TF to a target DNA sequence does not necessarily imply
direct transcriptional regulation. To assay the role of NF-Y
binding in gene expression, we infected HeLa and HCT116
cells with adenoviral vectors coding for an NF-YA dominant
negative protein (Ad-YA-m29) containing a mutation in the
DNA binding domain; the mutant still associates with the his-
tone fold NF-YB/NF-YC dimer but renders the trimer inca-
pable of CCAAT association (see reference 27 and references
therein). In parallel, we infected cells with wild-type Ad-
NF-YA and Ad-GFP viruses. Under these conditions, expres-
sion of CCAAT-containing, NF-Y-dependent promoters was
FIG. 4. Correlation between NF-Y binding and active histone marks. (A) Percentages of NF-Y TUs that scored positive for either H3K9-K14ac or
H3K4me3 or for both histone marks. (B) Percentages of H3K9-K14ac- or H3K4me3-positive TUs and of H3K9-K14ac/H3K4me3 double positives that
shared at least one NF-Y location. (C) Position of NF-Y binding sites and histone modification islands within a representative cluster of five genes.
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previously shown to be crippled (51). Figure 7 shows RT-PCR
analysis of expressed NF-Y targets associated with positive
histone marks (top); dominant negative YA treatment led to
decrease in expression of the genes analyzed, while little effects
were observed in the control wild-type Ad-GFP or Ad-NF-YA
infections. The mRNA levels of control, NF-Y-independent
genes such as GAPDH were unaffected. Similar results were
obtained with the HCT116 cells (Fig. 7, top right). In parallel,
we also analyzed NF-Y loci not expressed and associated with
negative histone marks; some of these genes, notably CYP24A1
and SERPIND, were clearly and specifically up-regulated by
the YA-m29 treatment, both in HeLa and in HCT116 cells.
Note that the former had high levels of H3K27me3 and low
H4K20me3; SERPIND showed the opposite pattern. SUHW1,
which was low on both these marks, was very modestly induced
by YA-m29. Interestingly, all these genes contain prototypical
CCAAT boxes in their promoters. We conclude that the pres-
ence of an active NF-Y trimer is required both for the expres-
sion of active genes and for repression of some of the NF-Y
targets associated with negative histone marks.
DISCUSSION
In this report, we correlate the in vivo binding of NF-Y with
the presence of H3-K9-14 acetylations and H3-K4 trimethyla-
tion using high-density arrays covering chromosome 21 and
large parts of chromosomes 20 and 22. We came to the fol-
lowing relevant conclusions. A majority of genes analyzed here
FIG. 5. Correlation between NF-Y binding, active histone marks, and gene expression. (A) NF-Y promoters were scored for the presence
(P) or absence (A) in the GSE6022 data set after the intersection with histone mark experiments. (B) Same as panel A, except that NF-Y genes
were analyzed. (C) An NF-Y locus within the promoter of a representative nonexpressed gene, devoid of active histone marks, is shown.
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are targeted by NF-Y, either in the promoter or in the 5 end
region of the gene. Functionally, two types of NF-Y loci exist:
one has active histone marks and correlates with transcription,
and the other is found in sites that are transcriptionally silent
and loaded with negative histone marks. NF-Y serves as an
activator of the former and as a repressor of the latter.
NF-Y location analysis. Several bioinformatic studies have
found CCAAT boxes in 60% of human promoters (19, 35,
48, 49); specific pathways, such as those involving cell cycle-
and endoplasmic reticulum stress-regulated genes, were found
to be quite enriched for CCAAT-containing genes (16, 50, 57).
Interestingly, analysis of microRNA control sequences identi-
fies NF-Y as one of the few TFs involved in the regulation of
all of them (29).
The first issue tackled here is how frequent are NF-Y bind-
ing sites. The answer to this depends, to some extent, upon the
stringency of the analysis. Monitoring 25 promoters (Fig. 1)
and validations of additional loci helped us fine-tune our anal-
ysis, so that we “lose” only 10 to 15% of the positive locations,
keeping the false-positive sites at the same level. The two
extremes range from 757 to 2,120 sites; the former is an abso-
lute minimum that considers only very-high-affinity sites, the
latter is a wider look at low-affinity sites or at sites present only
in a subcategory of cells, as ChIPs were made from a hetero-
geneous population. Extrapolation of these numbers to the
whole genome brings NF-Y sites to 35,000 to 80,000, which is
high compared to extrapolations performed for other TFs such
as E2F1 (20,000 to 30,000 binding sites [9]). However, it should
be noted that there are at least 200,000 NF-YB molecules
within the nuclei of various cell lines (R. Mantovani, unpub-
lished data). These data are consistent with the idea that NF-Y
is involved in a wide range of RNA production procedures,
both positive and negative; indeed, the TUs that contained at
least one NF-Y site are a majority, 519 out of 907.
The second issue tackled by this work concerns the presence
of the CCAAT consensus in the identified NF-Y sites. Previous
location analysis experiments performed with similar platforms
reported a low rate of consensus sites near locations of TFs (9,
11, 17), while others suggested significant variation from the in
vitro-derived consensus (56). It was found, using stringent cri-
teria, that 60% of NF-Y binding sites contain a CCAAT
consensus, particularly promoter sites. Furthermore, 1.5 to 2.5
CCAAT boxes per locus are found; thus, the presence of one
or more CCAAT boxes is in general important for NF-Y bind-
ing, in agreement with biochemical in vitro work (15). Note
that the total number of CCAAT-containing promoters in the
cluster analyzed here is 463 out of 907 (51%), which is lower
than the 60 to 67% derived from other studies (48). Nonethe-
less, around 35% of the identified NF-Y loci are apparently
devoid of CCAAT boxes. There are explanations for this find-
ing. (i) Variation of a single nucleotide in the CCAAT pen-
tanucleotide was reported to be compatible with NF-Y bind-
ing, especially when other functionally important overlapping
sites are involved (20, 37). A degenerate CCAAT box would be
FIG. 6. ChIP with negative histone marks in nonexpressed NF-Y loci. Twelve NF-Y/H3K9-K14ac/H3K4me3 sites, randomly selected
from the list of targets not expressed in HeLa cells (see File S7 in the supplemental material) were analyzed by ChIP with anti-NF-YB,
anti-H3K27me3, anti-H3K9me3, and anti-H4K20me3 antibodies. Enrichment over that for an irrelevant Flag control antibody was assessed by
semiquantitative PCR in duplicate experiments; enrichments greater than twofold were considered significant. The chromosome 11 satellite
centromeric region and the promoter of the transcribed NF-Y target SON were used as internal controls.
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missed in our stringent analysis. (ii) The ChIP-on-chip exper-
iments were performed with an anti-NF-YB antibody; since
NF-YB and NF-YC subunits are in excess with respect to
NF-YA (Mantovani, unpublished), some CCAAT-less sites de-
void of the sequence-specific NF-YA might have emerged.
The last point raised by our analysis is related to the genomic
location of the identified NF-Y binding sites. The CCAAT box
has long been considered almost exclusively as a promoter
element crucial for Pol II recruitment (24). In keeping with
expectations (33), the vast majority of NF-Y PR sites, 70%, are
positioned near the TSS, and there is clear enrichment of sites
near the TSS also within the GE cohort (Fig. 2). However,
NF-Y locations appear to be more scattered, and roughly 50%
of NF-Y-positive promoters contain an extra site within the
body of the gene (Fig. 2). It is possible that their role in many
such cases is related to promoter-enhancer connections, while
other GE locations could be alternative promoters of the same
gene or sites of divergent RNA production. Moreover, within
the EL cohort, a large number of sites are located in mRNA-
expressing areas, sites of Pol II activity. This accounts for 20%
of the 909 EL peaks (Table 1 and Fig. 2A). If we apply to these
Pol II/NF-Y units the same ratio of 2 sites/unit, as measured
in bona fide NF-Y RefSeq GE sites, at least 100 additional Pol
II units would be added. Extrapolation to the whole genome
gives 4,500 NF-Y units outside of the annotated RefSeq
genes. The remaining EL peaks could either be enhancer se-
quences located at a distance from transcribed regions or TUs
whose RNAs have not been annotated yet.
NF-Y, active histone marks, and transcription. It is clear
that H3K4me3 acetylation and H3K9-14 acetylation are hall-
marks of active genes (6, 40, 43). Our data for HeLa cells
confirm previous results for HepG2, obtained using similar
criteria of analysis (6). First of all we find an excellent corre-
lation between active mark islands and gene expression in
HeLa cells (see File S5 in the supplemental material). Second,
as the overlap between expressed and not expressed genes in
HeLa and HepG2 cells is quite high, 85%, we found a remark-
able degree of coincidence between histone mark sites in the
two cell lines, with deviations only for H3K4me3 within genes,
an effect due to cell type-specific patterns and/or to our un-
derestimation of such a category (see File S3 in the supple-
mental material). A similar picture emerged also by compari-
son with the data set of Guenther et al. (23), obtained with
human ES cells (see File S5I to K in the supplemental mate-
rial). As expected, skewing toward expression was less evident
for H3K4me3-positive promoters in ES cells.
NF-Y binding has been so far mostly associated with two
possible transcriptional states: an actively transcribing gene
and a poised promoter, with a prebound NF-Y ready to help
recruit whichever TF is specifically responsible for full activa-
tion, following a stimulus. Indeed, the majority of NF-Y-bound
units contain H3K9-14ac and H3K4me3 sites and are ex-
pressed. Note that active genes are expected to be readily
discernible in Affymetrix profiling data, while the levels of the
inducible ones might not, thus underscoring this already sig-
nificant correlation.
It has long been known that the binding of TFs and cofactors
to promoters is a hallmark of expression, by signaling to the
Pol II transcription machinery the positional coordinates (52).
It would seem logical, therefore, to postulate that positive
histone marks are positioned according to a code determined
by the sequence-specific TFs. Reassuringly, several studies
have confirmed that TF binding indeed correlates with the
presence of “active” marks and with gene expression. In a
thorough study performed with quantitative PCR on the cor-
relation between 30 histone modifications and MYC sites,
Guccione et al. (22) concluded that the presence of
H3K4me2/3, H3K9-14ac, and H3K79me2 is a prerequisite for
MYC binding. Interestingly, elimination of MYC had little
effect on the levels of these modifications, unlike what was
found for H4 acetylations, which were decreased (22). Clearly,
FIG. 7. Effects of NF-Y removal on gene expression. HeLa cells (left) were infected in parallel with control Ad-GFP, wild-type Ad-NF-YA,
and the dominant negative Ad-YAm29 adenovirus. RT-PCR analyses of infected cells were performed in the linear range of amplification for the
indicated genes. HCT116 cells (right) were analyzed under the same conditions. Western blot analysis confirmed equivalent overexpression of
wild-type NF-YA and of YAm29 proteins (not shown).
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this is not the case for NF-Y, since our unbiased analysis
identified NF-Y regions devoid of these active histone marks.
The most surprising result is the identification of the discrete
cohort of NF-Y TUs in which H3K9-14ac and H3K4me3
islands are absent and specifically enriched in A calls (almost
80%); this indicates that NF-Y is not always associated with
active/inducible transcription. This cluster comprises mostly
tissue-specific and developmentally regulated genes (see File
S7 in the supplemental material for a complete list) and is
associated with repressive histone marks such as H4K20me3
and H3K27me3. While hints at a negative role for NF-Y in
transcription had previously been reported (5, 27, 32, 53), we
are intrigued by the extent of this phenomenon, which involves
20 to 25% of the total binding sites. Significantly, we find that
removal of the NF-Y trimer leads to activation of these loci.
Among the derepressed, CYP24A1, but not SERPIND, is
H3K27me3. It is known that this modification is associated
with Polycomb (47); hints to a possible mechanism of repres-
sion through deposition of this negative mark come from re-
cent experiments with Caenorhabditis elegans, in which ceNF-Y
function has been genetically linked to Polycomb through di-
rect interaction with the ESC/E(Z) component (13).
The structural resemblance of NF-YB–NF-YC to H2A-H2B
should be remembered when considering the bifunctional be-
havior of NF-Y. The first sign of an opening chromatin cluster,
and one specifically required for H3K4me3, is monoubiquiti-
nation of H2B on K123 (28); we noted that lysines are present
in the corresponding region of the H2B-like NF-YB, and in-
deed NF-YB is monoubiquitinated (G. Donati and R. Man-
tovani, data not shown). On the other hand, H2A is mono-
ubiquitinated by Polycomb components, and the functional
significance of this modification is opposite to that of H2B-
ubiquitin, leading to repression of transcription (55). Thus,
H2A-ubiquitin could serve as a signal to recruit H3K27 meth-
yltransferase. Given the dual dominant NF-Y function uncov-
ered here, we are tempted to speculate that a code of post-
translational modifications may exist for the histone-like
NF-Y.
The bivalent behavior of NF-Y and its independence from a
specific pattern of activating versus repressive histone modifi-
cations might have important consequences for transcriptional
regulation at bivalent loci that have been recently mapped in
both ES and lineage-committed cells. At these sites, in fact, the
activating H3K4me3 and the repressive H3K27me3 are
present together on areas of the genome “poised” for alterna-
tive developmental fates (1, 7, 36). Interestingly, the role of
NF-Y in stem cells has been highlighted by two recent studies:
(i) NF-YA was shown to be required for maintenance of he-
matopoietic stem cells (58) and (ii) the CCAAT box was found
to be specifically enriched in conserved regions of genes highly
expressed in mouse and human ES cells, with NF-Y being
required both for regulation of these elements and for cell
survival (21). Moreover, a switch in the two major isoforms of
NF-YA was noticed upon differentiation, with the “short” form
being highest in stem cells and decreasing in embryonic bodies.
Note that this isoform is specifically required for stemness in
the hematopoietic system (58). These results, considered to-
gether with the widespread bifunctional role of NF-Y and its
independence from specific methyl marks shown here in com-
mitted HeLa cells, suggest that NF-Y might be associated with
bivalent sites in ES cells, possibly even regulating their posi-
tioning. Because of its structure and histone interactions (10),
NF-Y would be ideal to maintain nucleosome-free areas, ac-
commodate accessibility of nearby TFs, and recruit modifying
complexes, positive or negative. This hypothesis and the cause-
and-effect relationships between the positioning of histone
marks and NF-Y binding will now be investigated with appro-
priate genetic experiments.
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